ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression

• Published in: Scientific reports 2021-10, Vol.11 (1), p.20839-14, Article 20839
• Main Authors: Ma, Kaiming, Chen, Xin, Liu, Weihai, Yang, Yang, Chen, Suhua, Sun, Jianjun, Ma, Changcheng, Wang, Tao, Yang, Jun
• Format: Article
• Language: English
• Subjects: 692/308/53; 692/4028; 692/4028/546; 692/4028/67; 692/53; 692/53/2422; 692/699; 692/699/67; 692/699/67/1059; 692/699/67/1857; 692/699/67/1922; Annexin A2 - genetics; Annexin A2 - immunology; Brain tumors; Central Nervous System Neoplasms - diagnosis; Central Nervous System Neoplasms - genetics; Central Nervous System Neoplasms - immunology; Correlation analysis; Gene Expression Regulation, Neoplastic; Genomes; Glioma; Glioma - diagnosis; Glioma - genetics; Glioma - immunology; Humanities and Social Sciences; Humans; Immune response; Immune Tolerance; Immunoglobulin G; Immunoregulation; Immunosuppression; Inflammation; Interferon; Isocitrate dehydrogenase; Lck protein; Lymphocytes T; Macrophages; Major histocompatibility complex; Medical prognosis; Mesenchyme; Metastases; multidisciplinary; Phenotypes; Prognosis; Science; Science (multidisciplinary); Stat1 protein; Statistical analysis; Suppressor cells; Survival analysis; Up-Regulation
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-00366-8

Recent studies have shown that ANXA2 is important in the development of many cancers, while its role in glioma-related immune response remains unclear. We aimed to comprehensively investigate its biological characteristics and clinical value in glioma. We analyzed 699 glioma samples from The Cancer Genome Atlas as training cohort and 325 samples from the Chinese Glioma Genome Atlas as validation cohort. All the statistical analyses and figures were generated with R. ANXA2 was overexpressed significantly in high-grade glioma, isocitrate dehydrogenase wild-type and mesenchymal-subtype glioma. ANXA2 was a special indicator of mesenchymal subtype. The survival analysis showed that highly-expressed ANXA2 was related to worse survival status as an independent factor of poor prognosis. Further gene ontology analysis showed that ANXA2 was mainly involved in immune response and inflammatory activities of glioma. Subsequent correlation analysis showed that ANXA2 was positively correlated with HCK, LCK, MHC II, STAT1 and interferon but negatively with IgG. Meanwhile, ANXA2 was positively related to the infiltration of tumor-related macrophages, regulatory T cells and myeloid-derived suppressor cells. Our study revealed that ANXA2 is a biomarker closely related to the malignant phenotype and poor prognosis of glioma, and plays an important role in immune response, inflammatory activity and immunosuppression.